Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
Cancer Journal (Sudbury, Mass.)|January 24, 2018
PD-1/PD-L1 Axis in Lung CancerFernando C Santini, Matthew D HellmannImmunity|August 17, 2017
Making It Personal: Neoantigen Vaccines in Metastatic MelanomaMatthew D Hellmann, Alexandra SnyderCancer Cell|April 15, 2020
Acquired Resistance to Immune Checkpoint InhibitorsAdam J Schoenfeld, Matthew D HellmannExpert Review of Clinical Pharmacology|July 18, 2017
Atezolizumab for the treatment of non-small cell lung cancerFernando C Santini, Charles M RudinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
First-Line Immunotherapy for Non-Small-Cell Lung CancerMartin Reck, Jordi Remon, Matthew D HellmannClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
Use of Circulating Tumor DNA for Cancer ImmunotherapyAlexandra Snyder, Michael P Morrissey, Matthew D HellmannAdvances in Immunology|March 1, 2016
Combinatorial Cancer ImmunotherapiesMatthew D Hellmann, Claire F Friedman, Jedd D WolchokAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Chemotherapy for lung cancers: here to stayMark G Kris, Matthew D Hellmann, Jamie E ChaftLung Cancer (Amsterdam, Netherlands)|October 1, 2019
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)Ana C Z Gelatti, Alexander Drilon, Fernando C SantiniLung Cancer (Amsterdam, Netherlands)|September 26, 2021
NTRK fusions in lung cancer: From biology to therapyGuilherme Harada, Fernando C Santini, Clare Wilhelm, et al.Pageof 17